These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12847637)

  • 21. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Thomson JM; Wesley A; Byrnes CA; Nixon GM
    Pediatr Pulmonol; 2006 Feb; 41(2):164-70. PubMed ID: 16317722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic necrotizing pulmonary aspergillosis complicated by pneumothorax.
    Thurnheer R; Moll C; Röthlin M; Krause M
    Infection; 2004 Aug; 32(4):239-41. PubMed ID: 15293081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of pulmonary aspergilloma.
    Judson MA; Stevens DA
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1375-7. PubMed ID: 11890350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Parmar JS; Howell T; Kelly J; Bilton D
    Thorax; 2002 Aug; 57(8):749-50. PubMed ID: 12149540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole].
    Isobe Z; Suga T; Hamaguchi S; Hara K; Aoki N; Aoki F; Aoyagi K; Ueno M; Maeno T; Kurabayashi M
    Arerugi; 2007 Nov; 56(11):1390-6. PubMed ID: 18059153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicodynamics of itraconazole: implications for therapeutic drug monitoring.
    Lestner JM; Roberts SA; Moore CB; Howard SJ; Denning DW; Hope WW
    Clin Infect Dis; 2009 Sep; 49(6):928-30. PubMed ID: 19681707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Perspectives on allergic bronchopulmonary aspergillosis].
    Germaud P; Pipet A
    Rev Mal Respir; 2007 May; 24(5):659-61. PubMed ID: 17519821
    [No Abstract]   [Full Text] [Related]  

  • 28. Invasive aspergillosis associated with bevacizumab, a vascular endothelial growth factor inhibitor.
    Williams J; Lim R; Tambyah P
    Int J Infect Dis; 2007 Nov; 11(6):549-50. PubMed ID: 17336567
    [No Abstract]   [Full Text] [Related]  

  • 29. A rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxy-itraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosis.
    Redmann S; Charles BG
    Biomed Chromatogr; 2006 Apr; 20(4):343-8. PubMed ID: 16161186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioaerosol Imaging Predicts the Utility of Aerosolized Antifungal Therapy in Allergic Bronchopulmonary Aspergillosis.
    Rodriguez K; Siegel A
    Clin Nucl Med; 2018 Nov; 43(11):830-831. PubMed ID: 30199380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cystic fibrosis: current therapy. Allergic bronchopulmonary aspergillosis (ABPA)].
    Aebischer CC; Schöni MH
    Schweiz Med Wochenschr Suppl; 2000; 122():53S-54S. PubMed ID: 12536477
    [No Abstract]   [Full Text] [Related]  

  • 32. Rhabdomyolysis after the administration of itraconazole to an asthmatic patient with bronchopulmonary aspergillosis.
    Ferrari M; Bodini I; Lo Cascio V
    Respiration; 2004; 71(3):289-91. PubMed ID: 15133351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of ketoconazole in the treatment of bronchopulmonary aspergillosis].
    Grassi C; Manara G; Mangiarotti P
    G Ital Chemioter; 1982; 29(1):63-5. PubMed ID: 6309600
    [No Abstract]   [Full Text] [Related]  

  • 34. Tremor: a newly described adverse event with long-term itraconazole therapy.
    Lestner JM; Denning DW
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):327-9. PubMed ID: 20185472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis.
    Mannes GP; van der Heide S; van Aalderen WM; Gerritsen J
    Lancet; 1993 Feb; 341(8843):492. PubMed ID: 8094509
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy.
    Caras WE; Pluss JL
    Mayo Clin Proc; 1996 Jan; 71(1):25-30. PubMed ID: 8538227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of pulmonary aspergillosis effectively treated with itraconazole. Possible interaction of the antimycotic agent with hydroquinidine].
    Cruccu V; Pedretti D; Confalonieri F
    Clin Ter; 1995 May; 146(5):383-9. PubMed ID: 7796571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Havette A; Regard L; Roche N; Burgel PR
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 34887327
    [No Abstract]   [Full Text] [Related]  

  • 39. Hallucinations associated with itraconazole therapy.
    Cleveland KO; Campbell JW
    Clin Infect Dis; 1995 Aug; 21(2):456. PubMed ID: 8562772
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply: Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Agarwal R; Muthu V
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 34887329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.